Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference


NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ -- Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ)(NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)



Cision View original content to download multimedia:

SOURCE Johnson & Johnson

Company Codes: NYSE:JNJ

Back to news